Tag: Zeneca Group PLC

Saxagliptin

Durvalumab

Naproxen/esomeprazole

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC – Consensus Indicates Potential 11.8% Upside

Added to Collection on: 2021-05-31 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 23.0% Upside - DirectorsTalk Interviews

Added to Collection on: 2021-11-29 18:21:30

Tags for this article:

Bristol-Myers Squibb

Saxagliptin

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 1.0% Upside - DirectorsTalk Interviews

Added to Collection on: 2022-04-04 21:05:04

Tags for this article:

Glycopyrronium bromide/formoterol

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 7.7% Upside - DirectorsTalk Interviews

Added to Collection on: 2022-05-02 17:24:08

Tags for this article:

Dapagliflozin

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 17.8% Upside - DirectorsTalk Interviews

Added to Collection on: 2022-05-16 16:33:00

Tags for this article:

Dapagliflozin

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 12.2% Upside - DirectorsTalk Interviews

Added to Collection on: 2022-05-23 11:39:34

Tags for this article:

Dapagliflozin

Click the tags to see associated articles and topics

View Article Details

AstraZeneca (NASDAQ:AZN) versus MediciNova (NASDAQ:MNOV) Financial Comparison

Added to Collection on: 2022-08-03 05:13:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Comparing AstraZeneca (NASDAQ:AZN) & MediciNova (NASDAQ:MNOV)

Added to Collection on: 2022-08-07 08:00:32

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Astrazeneca PLC - Consensus Indicates Potential 8.7% Upside - DirectorsTalk Interviews

Added to Collection on: 2022-11-28 20:29:09

Tags for this article: